Literature DB >> 6091463

Secretion pattern of endogenous opioids in chronic schizophrenia.

F Brambilla, F Facchinetti, F Petraglia, L Vanzulli, A R Genazzani.   

Abstract

Baseline plasma levels of beta-endorphin, beta-lipotropin, and ACTH were assayed in 37 patients with chronic schizophrenia: 24 men and 13 women, 28 with hebephrenic and nine with paranoid schizophrenia. None of the patients had received any medication for at least 10 days. The mean values of both opioids were significantly higher in the schizophrenic patients than in 21 age- and sex-matched control subjects. Insulin stimulation and dexamethasone suppression tests were given to eight of the patients, and the circadian rhythms of beta-endorphin, beta-lipotropin, ACTH, and cortisol were assayed in the same eight patients. Insulin stimulation, dexamethasone suppression test results, or circadian rhythmicity was impaired in seven of these eight patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091463     DOI: 10.1176/ajp.141.10.1183

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  6 in total

1.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

Review 2.  Opioids and behavior: genetic aspects.

Authors:  H R Frischknecht; B Siegfried; P G Waser
Journal:  Experientia       Date:  1988-06-15

3.  Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms.

Authors:  Małgorzata Urban-Kowalczyk; Justyna Pigońska; Janusz Śmigielski
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-06       Impact factor: 2.570

4.  The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Magdalena Kotlicka-Antczak; Dominik Strzelecki; Ewa Rudecka; Janusz Śmigielski
Journal:  Neuropsychiatr Dis Treat       Date:  2019-12-31       Impact factor: 2.570

5.  Reduced mu opioid receptor availability in schizophrenia revealed with [11C]-carfentanil positron emission tomographic Imaging.

Authors:  Abhishekh H Ashok; Jim Myers; Tiago Reis Marques; Eugenii A Rabiner; Oliver D Howes
Journal:  Nat Commun       Date:  2019-10-03       Impact factor: 14.919

6.  The Relationship Between Antipsychotic Treatment and Plasma β-Endorphin Concentration in Patients with Schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Magdalena Kotlicka-Antczak; Dominik Strzelecki; Ewa Rudecka; Janusz Śmigielski
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-16       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.